Source: Eur Respir J 2006; 27: 644-646
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Jaffre S., Jardin F., Dominique S., Duet E., Hubscher Ph., Genevois A., Corne F., Bota S., Nouvet G., Thiberville L.. Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab. Eur Respir J 2006; 27: 644-646

Member's Comments

No comment yet.

Related content which might interest you: Granulomatosis with polyangiitis (Wegener&s) Source: Eur Respir Mon 2011; 54: 1-14 Year: 2011 Pulmonary hypertension as the first manifestation in a patient with granulomatosis with polyangiitis Source: International Congress 2019 – Pulmonary vascular diseases? Year: 2019 Relapsing necrotising sarcoid granulomatosis in a young patient Source: Eur Respir J 2007; 29: 816 Year: 2007 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2022; 95: 177-192 Year: 2022 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 188-209 Year: 2019 Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020 Year: 2020 Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (1) 00311-2019; 10.1183/23120541.00311-2019 Year: 2020 Wegener's granulomatosis after Montelukast in patient not receiving systemic steroid treatment Source: Eur Respir J 2002; 20: Suppl. 38, 65s Year: 2002 A case of Wegener granulomatosis that mimics metastatic pulmonary tumor and progresses with eosinophilia Source: Annual Congress 2007 - Granulomatous lung diseases including sarcoidosis Year: 2007 Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69 Year: 2005 Mepolizumab as a steroid-sparing agent for eosinophilic granulomatosis with poliangiitis: a case series Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Twelve month outcomes with Reslizumab treatment of Eosinophilic Granulomatosis with Polyangiitis Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Aerosolized tobramycin in patients with Wegener's granulomatosis Source: Eur Respir J 2001; 18: Suppl. 33, 138s Year: 2001 Wegener's granulomatosis: our experience Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001 Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) Source: Eur Respir J 2016; 48: 1429-1441 Year: 2016 Biologics for eosinophilic granulomatosis with polyangiitis Source: Short video statement 2020 Year: 2020 New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now? Source: Eur Respir J 2015; 46: 1255-1258 Year: 2015